Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Cellebrite DI (CLBT) over the last 6 years, with Q2 2025 value amounting to $17.6 million.

  • Cellebrite DI's Change in Accured Expenses rose 18822.37% to $17.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $26.4 million, marking a year-over-year increase of 26863.73%. This contributed to the annual value of $17.6 million for FY2024, which is 229591.28% up from last year.
  • Per Cellebrite DI's latest filing, its Change in Accured Expenses stood at $17.6 million for Q2 2025, which was up 18822.37% from -$12.2 million recorded in Q1 2025.
  • Over the past 5 years, Cellebrite DI's Change in Accured Expenses peaked at $17.6 million during Q2 2025, and registered a low of -$12.2 million during Q1 2025.
  • For the 5-year period, Cellebrite DI's Change in Accured Expenses averaged around $1.1 million, with its median value being $2.4 million (2021).
  • Per our database at Business Quant, Cellebrite DI's Change in Accured Expenses plummeted by 18484.35% in 2022 and then soared by 80928.07% in 2024.
  • Quarter analysis of 5 years shows Cellebrite DI's Change in Accured Expenses stood at $2.4 million in 2021, then tumbled by 184.84% to -$2.1 million in 2022, then soared by 370.44% to $5.6 million in 2023, then soared by 110.41% to $11.7 million in 2024, then surged by 50.33% to $17.6 million in 2025.
  • Its last three reported values are $17.6 million in Q2 2025, -$12.2 million for Q1 2025, and $11.7 million during Q4 2024.